» Articles » PMID: 38789909

Enhancing the Oral Bioavailability of Fisetin: Polysaccharide-based Self Nano-emulsifying Spheroids for Colon-targeted Delivery

Abstract

Fisetin (FS) is a flavonoid that possesses antioxidant and anti-inflammatory properties against ulcerative colitis. FS shows poor dissolution rate and permeability. An attempt has been made to develop colon-targeted solid self-nanoemulsifying drug delivery systems (S-SNEDDS) of FS. Initially, liquid (L) SNEDDS were prepared by loading FS into isotropic mixture of L-SNEDDS was prepared using Labrafil M 1944 CS, Transcutol P, and Tween 80. These L-SNEDDS were further converted into solid (S) SNEDDS by mixing the isotropic mixture with 1:1:1 ratio of guar gum (GG), xanthan gum (XG) and pectin (PC) [GG:XG:PC (1:1:1)]. Aerosil-200 (A-200) was added to enhance their flow characteristics. Further, they were converted into spheroids by extrusion-spheronization technique. The solid-state characterization of S-SNEDDS was done by SEM, DSC, and PXRD, which revealed that the crystalline form of FS was converted into the amorphous form. In the dissolution study, S-SNEDDS spheroids [GG:XG:PC (1:1:1)] exhibited less than 20% drug release within the first 5 h, followed by rapid release of the drug between the 5th and 10th h, indicating its release at colonic site. The site-specific delivery of FS to colon via FS-S-SNEDDS spheroids was confirmed by conducting pharmacokinetic studies on rats. Wherein, results showed delay in absorption of FS loaded in spheroids up to 5 h and achievement of Cmax at 7h, whereas L-SNEDDS showed rapid absorption of FS. Furthermore, FS-L-SNEDDS and FS-S-SNEDDS spheroids [GG:XG:PC (1:1:1)] increased oral bioavailability of FS by 6.86-fold and 4.44-fold, respectively, as compared to unprocessed FS.

Citing Articles

Fisetin as a chemoprotective and chemotherapeutic agent: mechanistic insights and future directions in cancer therapy.

Fatima R, Soni P, Sharma M, Prasher P, Kaverikana R, Mangalpady S Med Oncol. 2025; 42(4):104.

PMID: 40074915 DOI: 10.1007/s12032-025-02664-x.


Exploring the therapeutic promise of fisetin: molecular mechanisms and clinical aspects in lung cancer.

Goyal K, Babu M, Afzal M, Rekha A, Ali H, Gupta S J Complement Integr Med. 2025; .

PMID: 40013371 DOI: 10.1515/jcim-2024-0444.


Self-Emulsifying Drug Delivery Systems (SEDDS): Transition from Liquid to Solid-A Comprehensive Review of Formulation, Characterization, Applications, and Future Trends.

Uttreja P, Karnik I, Youssef A, Narala N, Elkanayati R, Baisa S Pharmaceutics. 2025; 17(1).

PMID: 39861711 PMC: 11768142. DOI: 10.3390/pharmaceutics17010063.

References
1.
Mohanta S, Singh S, Kumar B, Gulati M, Kumar R, Kumar Yadav A . Efficacy of co-administration of modified apple polysaccharide and probiotics in guar gum-Eudragit S100 based mesalamine mini tablets: A novel approach in treating ulcerative colitis. Int J Biol Macromol. 2018; 126:427-435. DOI: 10.1016/j.ijbiomac.2018.12.154. View

2.
McCoubrey L, Favaron A, Awad A, Orlu M, Gaisford S, Basit A . Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics. J Control Release. 2022; 353:1107-1126. DOI: 10.1016/j.jconrel.2022.12.029. View

3.
Philip A, Philip B . Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J. 2011; 25(2):79-87. PMC: 3215502. DOI: 10.5001/omj.2010.24. View

4.
Elghouneimy M, Ramadan M, Farrag E, Ibrahim H, Khirala S, Seliem N . Impact of miR-155 rs767649 Polymorphism on Rheumatoid Arthritis Activity in Egyptian Patients. Cureus. 2024; 15(11):e49297. PMC: 10862083. DOI: 10.7759/cureus.49297. View

5.
Hanmantrao M, Chaterjee S, Kumar R, Vishwas S, Harish V, Porwal O . Development of Guar Gum-Pectin-Based Colon Targeted Solid Self-Nanoemulsifying Drug Delivery System of Xanthohumol. Pharmaceutics. 2022; 14(11). PMC: 9693267. DOI: 10.3390/pharmaceutics14112384. View